Literature DB >> 12623278

Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice.

Robert B Ashman1, John M Papadimitriou, Alma Fulurija, Karen E Drysdale, Camile S Farah, Owen Naidoo, Theo Gotjamanos.   

Abstract

The aims of the study were to compare the pathogenesis of Candida albicans infection in various organs and anatomical regions of C5-deficient (DBA/2) and C5-sufficient (BALB/c) mice, and to evaluate the importance of complement C5 and T lymphocytes as factors that determine host susceptibility or resistance. The kidneys of DBA/2 mice showed higher colonisation and more severe tissue damage than those of BALB/c, but infection at other sites, including oral and vaginal mucosa, was generally similar in the two strains. Passive transfer of C5-sufficient serum into DBA/2 mice decreased the fungal burden in the kidney, and prolonged survival of the reconstituted animals. Depletion of CD4(+) and/or CD8(+) cells did not exacerbate either systemic or mucosal infection when compared to controls, and passive transfer of splenocytes from infected donors caused only a small and transient reduction in numbers of yeasts recovered from the kidney of sub-lethally infected recipients. It is concluded that the acute susceptibility of the kidneys in this mouse strain is due to C5 deficiency expressed on a susceptible genetic background. T lymphocytes, however, appear to have minimal influence on recovery from systemic infection with this isolate of C. albicans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623278     DOI: 10.1016/s0882-4010(02)00211-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  17 in total

1.  Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

Review 2.  Th17 cells in immunity to Candida albicans.

Authors:  Nydiaris Hernández-Santos; Sarah L Gaffen
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

3.  Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.

Authors:  Hong Xin
Journal:  Vaccine       Date:  2015-11-25       Impact factor: 3.641

4.  Reasons why DBA/2 mice are resistant to malarial infection: expansion of CD3int B220+ gammadelta T cells with double-negative CD4- CD8- phenotype in the liver.

Authors:  Hanaa Y Bakir; Chikako Tomiyama-Miyaji; Hisami Watanabe; Toru Nagura; Toshihiko Kawamura; Hiroho Sekikawa; Toru Abo
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

5.  Next-generation computational genetic analysis: multiple complement alleles control survival after Candida albicans infection.

Authors:  Gary Peltz; Aimee K Zaas; Ming Zheng; Norma V Solis; Mason X Zhang; Hong-Hsing Liu; Yajing Hu; Gayle M Boxx; Quynh T Phan; David Dill; Scott G Filler
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

6.  Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Authors:  Alaka Mullick; Miria Elias; Serge Picard; Lucie Bourget; Orce Jovcevski; Susan Gauthier; Ashleigh Tuite; Penelope Harakidas; Craig Bihun; Bernard Massie; Philippe Gros
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 7.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

8.  Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 9.  The aryl hydrocarbon receptor in innate T cell immunity.

Authors:  Jörg Stange; Marc Veldhoen
Journal:  Semin Immunopathol       Date:  2013-09-13       Impact factor: 9.623

Review 10.  Candidiasis--do we need to fight or to tolerate the Candida fungus?

Authors:  M Raska; J Bĕláková; M Krupka; E Weigl
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.